JP2020524141A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020524141A5 JP2020524141A5 JP2019569454A JP2019569454A JP2020524141A5 JP 2020524141 A5 JP2020524141 A5 JP 2020524141A5 JP 2019569454 A JP2019569454 A JP 2019569454A JP 2019569454 A JP2019569454 A JP 2019569454A JP 2020524141 A5 JP2020524141 A5 JP 2020524141A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- composition
- seq
- polypeptide
- elane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022192891A JP7529754B2 (ja) | 2017-06-15 | 2022-12-01 | がんを処置するための方法および組成物 |
| JP2024119305A JP2024150679A (ja) | 2017-06-15 | 2024-07-25 | がんを処置するための方法および組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762520325P | 2017-06-15 | 2017-06-15 | |
| US62/520,325 | 2017-06-15 | ||
| US201762610711P | 2017-12-27 | 2017-12-27 | |
| US62/610,711 | 2017-12-27 | ||
| PCT/US2018/037800 WO2018232273A1 (en) | 2017-06-15 | 2018-06-15 | Methods and compositions for treating cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022192891A Division JP7529754B2 (ja) | 2017-06-15 | 2022-12-01 | がんを処置するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020524141A JP2020524141A (ja) | 2020-08-13 |
| JP2020524141A5 true JP2020524141A5 (cg-RX-API-DMAC10.html) | 2021-09-09 |
| JP7189160B2 JP7189160B2 (ja) | 2022-12-13 |
Family
ID=64659547
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019569454A Active JP7189160B2 (ja) | 2017-06-15 | 2018-06-15 | がんを処置するための方法および組成物 |
| JP2022192891A Active JP7529754B2 (ja) | 2017-06-15 | 2022-12-01 | がんを処置するための方法および組成物 |
| JP2024119305A Pending JP2024150679A (ja) | 2017-06-15 | 2024-07-25 | がんを処置するための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022192891A Active JP7529754B2 (ja) | 2017-06-15 | 2022-12-01 | がんを処置するための方法および組成物 |
| JP2024119305A Pending JP2024150679A (ja) | 2017-06-15 | 2024-07-25 | がんを処置するための方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12564623B2 (cg-RX-API-DMAC10.html) |
| EP (2) | EP3638293B1 (cg-RX-API-DMAC10.html) |
| JP (3) | JP7189160B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN111032075A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2018285710B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3066738A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK3638293T5 (cg-RX-API-DMAC10.html) |
| ES (2) | ES2962985T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2018232273A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119015448A (zh) | 2018-12-20 | 2024-11-26 | 芝加哥大学 | 与用于癌症疗法的治疗肽相关的方法和组合物 |
| CN116261592A (zh) * | 2020-08-18 | 2023-06-13 | 昂希莱斯制药公司 | 经修饰的丝氨酸蛋白酶前蛋白 |
| EP4199947A4 (en) * | 2020-08-18 | 2024-10-16 | Onchilles Pharma, Inc. | Modified porcine pancreatic elastase proteins |
| CN112812150A (zh) * | 2021-01-29 | 2021-05-18 | 深圳海创生物科技有限公司 | 一种活性环肽、活性环肽组合物及其在制备具有抗氧化或抗炎作用的产品中的应用 |
| CN113736742B (zh) * | 2021-09-08 | 2023-07-21 | 河南省医药科学研究院 | Prtn3基因作为肿瘤免疫治疗中激活细胞毒性免疫细胞靶点的应用 |
| CN115040642B (zh) * | 2022-06-30 | 2025-03-28 | 德博尔(成都)生物科技有限公司 | 一种胰弹性蛋白酶的新用途 |
| CN118443941A (zh) * | 2024-04-29 | 2024-08-06 | 山东大学齐鲁医院 | 中性粒细胞作为诊疗膀胱癌的靶标的应用 |
| CN121588088A (zh) * | 2025-12-30 | 2026-03-03 | 西安交通大学 | Sivelestat在制备癌症放射治疗辅助药物中的应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3941763A (en) | 1975-03-28 | 1976-03-02 | American Home Products Corporation | PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| AU662104B2 (en) | 1990-08-03 | 1995-08-24 | Vertex Pharmaceuticals Incorporated | Use of crosslinked crystals as a novel form of enzyme immobilization |
| US5698518A (en) * | 1994-03-30 | 1997-12-16 | Oklahoma Medical Research Foundation | Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists |
| WO2003083084A2 (en) * | 2002-03-29 | 2003-10-09 | Incyte Corporation | Protein modification and maintenance molecules |
| AU2003249012A1 (en) | 2002-09-30 | 2004-04-23 | Japan As Represented By The President Of The University Of Tokyo | Genes and polypeptides relating to human myeloid leukemia |
| JP4408615B2 (ja) | 2002-10-07 | 2010-02-03 | 独立行政法人科学技術振興機構 | 好酸球カチオン性タンパク質を含有する組成物 |
| US8068990B2 (en) | 2003-03-25 | 2011-11-29 | Hologic, Inc. | Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids |
| US20060019256A1 (en) | 2003-06-09 | 2006-01-26 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| ES2316997T3 (es) | 2003-07-21 | 2009-04-16 | F. Hoffmann-La Roche Ag | Uso de la proteina proteinasa 3 (prn3) y del inhibidor de la elastasa leucocitaria (ileu) como un marcador para el cancer colorrectal. |
| US7432419B2 (en) | 2004-05-14 | 2008-10-07 | Los Alamos National Security, Llc | Compositions and methods for the treatment of Pierce's disease |
| US20060008891A1 (en) | 2004-06-23 | 2006-01-12 | The Government Of Usa As Repersented By The Secretary, Department Of Health And Human Services | Cathepsin G-related peptides as modulators of formylpeptide receptors (FPR) |
| US20060045881A1 (en) | 2004-08-26 | 2006-03-02 | Board Of Regents, The University Of Texas System | Anti-cancer vaccines |
| US8501449B2 (en) * | 2007-12-04 | 2013-08-06 | Proteon Therapeutics, Inc. | Recombinant elastase proteins and methods of manufacturing and use thereof |
| MX2011000655A (es) * | 2008-07-18 | 2011-03-21 | Oragenics Inc | Composiciones para la deteccion y tratamiento de cancer colorrectal. |
| GB201121070D0 (en) | 2011-12-07 | 2012-01-18 | Isis Innovation | composition for delivery of biotherapeutics |
| WO2016125330A1 (ja) * | 2015-02-02 | 2016-08-11 | 原 英彰 | 網膜再生促進薬 |
-
2018
- 2018-06-15 WO PCT/US2018/037800 patent/WO2018232273A1/en not_active Ceased
- 2018-06-15 US US16/621,549 patent/US12564623B2/en active Active
- 2018-06-15 EP EP18817894.1A patent/EP3638293B1/en active Active
- 2018-06-15 ES ES18817894T patent/ES2962985T3/es active Active
- 2018-06-15 AU AU2018285710A patent/AU2018285710B2/en active Active
- 2018-06-15 ES ES23191473T patent/ES3055526T3/es active Active
- 2018-06-15 JP JP2019569454A patent/JP7189160B2/ja active Active
- 2018-06-15 DK DK18817894.1T patent/DK3638293T5/da active
- 2018-06-15 CN CN201880053084.1A patent/CN111032075A/zh active Pending
- 2018-06-15 EP EP23191473.0A patent/EP4292606B1/en active Active
- 2018-06-15 CA CA3066738A patent/CA3066738A1/en active Pending
-
2022
- 2022-12-01 JP JP2022192891A patent/JP7529754B2/ja active Active
-
2024
- 2024-07-25 JP JP2024119305A patent/JP2024150679A/ja active Pending
-
2026
- 2026-01-27 US US19/461,605 patent/US20260144854A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017529059A5 (cg-RX-API-DMAC10.html) | ||
| WO2012094653A4 (en) | Compositions and methods for macromolecular drug delivery | |
| JP2020509737A5 (cg-RX-API-DMAC10.html) | ||
| US20170260246A1 (en) | Carcinoma homing peptide (chp), its analogs, and methods of using | |
| CN102936281B (zh) | 一种rTRAIL突变体及其海兔毒素偶联物 | |
| JP2020517658A5 (cg-RX-API-DMAC10.html) | ||
| JP2023145635A (ja) | 免疫調節特性を有するペプチド | |
| McGonigle et al. | Neuropilin-1 drives tumor-specific uptake of chlorotoxin | |
| US20240197903A1 (en) | Tnf-alpha immunoconjugate therapy for the treatment of brain tumors | |
| CN107206103A (zh) | 用于治疗目的的抗体‑脲酶缀合物 | |
| CN116789837B (zh) | 一种抗组织因子人源化抗体及制备的抗体偶联药物和应用 | |
| Sui et al. | Lipid nanoparticle-mediated targeted mRNA delivery and its application in cancer therapy | |
| RU2014145841A (ru) | Терапевтический биопрепарат для лечения гепатоцеллюлярной карциномы | |
| WO2016186445A1 (ko) | 암 세포 표적용 펩타이드 및 이의 용도 | |
| JP2022535816A5 (cg-RX-API-DMAC10.html) | ||
| Tao et al. | Multivalent assembly of nucleolin-targeted F3 peptide potentiates TRAIL's tumor penetration and antitumor effects | |
| CA3109702A1 (en) | Peptides and compositions for targeted treatment and imaging | |
| JP2022514354A5 (cg-RX-API-DMAC10.html) | ||
| Beswick | Bicycles—An entirely new class of therapeutics | |
| CN115028738B (zh) | 一种Fc融合蛋白双重靶向降解剂及应用 | |
| Wang et al. | A bifunctional peptide–selenium nanocomposite for lysosomal degradation of PD-L1 and enhanced cancer immunotherapy | |
| US20220143130A1 (en) | Peptides Having Immunomodulatory Properties | |
| JP2023536961A5 (cg-RX-API-DMAC10.html) | ||
| CN115804853A (zh) | 包含rna分子的组合物及其在制备瘤内注射剂中的用途 | |
| CN105985447A (zh) | 一种白蛋白结合型肿瘤坏死因子相关凋亡诱导配体变异体及其制备方法和用途 |